Osteogenic signaling pathway

Osteogenic signaling pathway refers to a collection of interconnected molecular cascades that regulate the differentiation of mesenchymal stem cells (MSCs) into osteoblasts, which are responsible for bone formation. These pathways include Wnt/β-catenin, Notch, Hedgehog, bone morphogenetic protein (BMP), insulin-like growth factor (IGF), and parathyroid hormone (PTH) signaling[3][5][2]. The balance between osteogenic and adipogenic differentiation is tightly controlled by these signals through master transcription factors such as Runx2 and PPARγ[3]. These pathways do not represent a single molecule or druggable target but rather a network of regulatory mechanisms essential for skeletal development and homeostasis. Disruption in these pathways can lead to diseases like osteoporosis or impaired bone regeneration[3][5]. Note on correctness: "Osteogenic signaling pathway" is not a specific molecule or canonical therapeutic target such as an enzyme or receptor; it describes multiple biological processes involving various proteins and receptors. Therefore, it should not be considered a single druggable entity but rather an umbrella term for several interrelated molecular targets involved in bone biology[3][5].

Other names

Osteogenesis pathwaysBone formation signaling pathwaysMSC osteogenic differentiation pathways